FI971203A0 - DNA-kodande människopapillomavirus typ 6A - Google Patents

DNA-kodande människopapillomavirus typ 6A

Info

Publication number
FI971203A0
FI971203A0 FI971203A FI971203A FI971203A0 FI 971203 A0 FI971203 A0 FI 971203A0 FI 971203 A FI971203 A FI 971203A FI 971203 A FI971203 A FI 971203A FI 971203 A0 FI971203 A0 FI 971203A0
Authority
FI
Finland
Prior art keywords
human papillomavirus
dna coding
papillomavirus type
coding human
type
Prior art date
Application number
FI971203A
Other languages
English (en)
Finnish (fi)
Other versions
FI971203A (sv
FI121507B (sv
Inventor
Kathrin U Jansen
Kathryn J Hoffmann
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23202654&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI971203(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI971203A publication Critical patent/FI971203A/sv
Publication of FI971203A0 publication Critical patent/FI971203A0/sv
Application granted granted Critical
Publication of FI121507B publication Critical patent/FI121507B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
FI971203A 1994-09-22 1997-03-21 DNA-kodande människopapillomavirus typ 6A FI121507B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US31046894A 1994-09-22 1994-09-22
US31046894 1994-09-22
US9511859 1995-09-18
PCT/US1995/011859 WO1996009375A1 (en) 1994-09-22 1995-09-18 Dna encoding human papillomavirus type 6a

Publications (3)

Publication Number Publication Date
FI971203A FI971203A (sv) 1997-03-21
FI971203A0 true FI971203A0 (sv) 1997-03-21
FI121507B FI121507B (sv) 2010-12-15

Family

ID=23202654

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971203A FI121507B (sv) 1994-09-22 1997-03-21 DNA-kodande människopapillomavirus typ 6A

Country Status (16)

Country Link
US (1) US6290965B1 (sv)
EP (1) EP0782615A4 (sv)
JP (1) JPH10506014A (sv)
AU (1) AU694269B2 (sv)
BG (1) BG101338A (sv)
BR (1) BR9509076A (sv)
CA (1) CA2200582C (sv)
CZ (1) CZ87597A3 (sv)
FI (1) FI121507B (sv)
HU (1) HUT77337A (sv)
NO (1) NO971347L (sv)
NZ (1) NZ293461A (sv)
PL (1) PL319294A1 (sv)
RU (1) RU2177999C2 (sv)
SK (1) SK35897A3 (sv)
WO (1) WO1996009375A1 (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6962981B1 (en) * 1996-03-25 2005-11-08 Medarex, Inc. Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
BR9913026A (pt) * 1998-08-14 2001-09-25 Merck & Co Inc Processo de purificação de partìculas semelhantes a vìrus (vlps) de papilomavìrus recombinante, e, processo de preparação de um produto de vlp de papilomavìrus humano purificado adequado para uso em uma vacina para humano
CN1100835C (zh) * 1998-10-30 2003-02-05 中国科学院感光化学研究所 加入纳米无机化合物粒子的钛溶胶－凝胶涂料及其制法和用途
GB0017990D0 (en) * 2000-07-21 2000-09-13 Glaxo Group Ltd Papilloma virus sequences
WO2004081178A2 (en) * 2003-03-06 2004-09-23 Indiana University Research And Technology Corporation Methods and composition for producing infectious hpv stocks
IL156670A0 (en) * 2003-06-26 2004-01-04 Zvi Zolotariov Aloe suppositories
US20080160040A1 (en) * 2004-04-15 2008-07-03 Ghim Shin-Je Plant-produced compositions for treating papillomavirus infection and related methods
US7354719B2 (en) 2004-12-08 2008-04-08 Gen-Probe Incorporated Detection of nucleic acids from multiple types of human papillomaviruses
US8084207B2 (en) * 2005-03-03 2011-12-27 Ibis Bioscience, Inc. Compositions for use in identification of papillomavirus
US20070031826A1 (en) * 2005-08-05 2007-02-08 My Gene Diagnostic kit for determining the genotype of a human papilloma virus and method of using thereof
EP1934335A4 (en) * 2005-09-08 2010-05-05 Large Scale Biology Corp MODIFIED TOBACCO MOSAIC VIRUS PARTICLES AS MEDIA FOR THE DISPOSAL OF PROTEIN ANTIGENS FOR VACCINE APPLICATIONS
WO2008026869A1 (en) * 2006-08-28 2008-03-06 Sungkyunkwan University Foundation For Corporate Collaboration A dna vaccine for treating or preventing cervical cancer comprising a gene encoding hpv protein
US20110045536A1 (en) * 2007-12-21 2011-02-24 Novartis Ag Mammalian expression vector
AU2011258501B2 (en) 2010-05-25 2016-07-07 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically-truncated probes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT647140E (pt) * 1992-06-25 2007-12-27 Univ Georgetown Vacinas de papilomavírus
CN1152935A (zh) * 1994-05-16 1997-06-25 麦克公司 乳头状瘤病毒疫苗
AR004464A1 (es) * 1994-11-14 1998-12-16 Merck Sharp & Dohme Un metodo para producir una proteina de capside de papilomavirus
IL117591A0 (en) * 1995-03-30 1996-07-23 Merck & Co Inc Synthetic DNA encoding human papillomavirus type 11 L1 protein

Also Published As

Publication number Publication date
FI971203A (sv) 1997-03-21
NO971347L (no) 1997-05-21
SK35897A3 (en) 1998-02-04
EP0782615A4 (en) 2001-08-22
JPH10506014A (ja) 1998-06-16
EP0782615A1 (en) 1997-07-09
BR9509076A (pt) 1998-07-14
MX9702209A (es) 1997-07-31
PL319294A1 (en) 1997-08-04
CA2200582A1 (en) 1996-03-28
BG101338A (en) 1997-10-31
HUT77337A (hu) 1998-03-30
NZ293461A (en) 1998-04-27
WO1996009375A1 (en) 1996-03-28
CA2200582C (en) 2007-03-27
AU3591895A (en) 1996-04-09
CZ87597A3 (cs) 1998-01-14
AU694269B2 (en) 1998-07-16
NO971347D0 (no) 1997-03-21
FI121507B (sv) 2010-12-15
US6290965B1 (en) 2001-09-18
RU2177999C2 (ru) 2002-01-10

Similar Documents

Publication Publication Date Title
NO982453D0 (no) Bar stol
FI970038A (sv) Fuktgivande preparat
DE59701476D1 (de) Zahnpflegegerät mit auswechselbarem pflegeteil
FI971203A (sv) DNA-kodande människopapillomavirus typ 6A
DE59505759D1 (de) Binderrücken
DE69509766D1 (de) Mikroemulsionen
DK0772988T3 (da) Stol
DE69532881D1 (de) Ecdn - protein und dafuer kodeierende dna
DK48194A (da) Medicinsk elektrode
NO971363D0 (no) Human galaktokinasegen
NO303613B1 (no) Anordning ved stillbar stol
DE9410095U1 (de) Kamm
IT233504Y1 (it) Pannolino-mutandina monouso, particolarmente per incontinenti
SE9702576D0 (sv) Ryggavlastande stol
IT1294608B1 (it) Tandem scomponibile
IT1294607B1 (it) Tandem scomponibile
KR950024720U (ko) 봉투가 불필요한 편지지
FI3553U1 (sv) Stol
SE9801505D0 (sv) Stol
FI951293A0 (fi) Stol
FI952476A0 (fi) Stol
FI2504U1 (sv) Stol
KR950026482U (ko) 교체형 칫솔
SE9604136D0 (sv) Stol
SE9701730D0 (sv) Stol

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: MERCK SHARP & DOHME CORP.

Free format text: MERCK SHARP & DOHME CORP.

PC Transfer of assignment of patent

Owner name: MERCK SHARP & DOHME CORP.

MA Patent expired